HONG KONG – Onquality Pharmaceuticals LLC raised an additional $20 million from a series A+ financing round, bringing its amount of capital raised to $35 million.
Med-tech firms raising money in public or private financings, including: Bausch Health, Better Therapeutics, CA Healthcare, Carta Healthcare, CM Life Sciences III, Firefly Health, Lumiradx, Mountain Crest, Orchid, Phreesia, Privia Health Group, Vizgen.
The biopharmaceutical sector is showing no signs of slowing the pace of attracting capital. After coming off a record year, global private and public companies collectively raised $37 billion in the first quarter, indicating that it could be another bumper year for financings.
Biopharmas raising money in public or private financings, including: Achilles, ACM, Applied Molecular, CM Life Sciences, Delta 4, Homology, Humanigen, Icosavax, Innovatus Life Sciences, Ionis, Metagenomi, Panacea Acquisition, Xoma.
Pixium Vision SA reported that its merger with Second Sight Medical Products Inc. has foundered. The combination would have eased Paris-based Pixium’s entry into the U.S. market and Sylmar, Calif.-based Second Sight’s access to the European market, which Pixium has previously opposed, and enabled them to jointly develop and market neuromodulation devices that restore some degree of vision to the blind. The deal had been expected to close early in the second quarter of 2021.
RSS
